Anticancer drugs might be of benefit to sickle-cell patients

Dec 06, 2007

Sickle cell disease (SCD) is an inherited blood disorder caused by a genetic mutation that leads to the generation of a mutant form of the beta-globin chain of hemoglobin (Hb). Red blood cells containing Hb with this mutant beta-globin chain change shape upon deoxygenation and this causes them to get stuck in blood vessels, depriving the surrounding tissues of oxygen, which can lead to organ damage.

Although hydroxyurea, a treatment for SCD that works by increasing fetal Hb (HbF) expression, benefits some adults with moderate and severe SCD, it does not work for all individuals. Now, hope for a new therapy for SCD has been provided by the work of Laure A. Moutouh-de Parseval and colleagues working for Celgene Corporation.

In the study, lenalidomide and pomalidomide, immunomodulatory anticancer drugs, were both shown to be more effective than hydroxyurea at inducing HbF expression by erythrocytes derived in vitro from CD34+ cells from healthy individuals. In addition, the effects of pomalidomide and hydroxyurea on HbF expression were synergistic.

As pomalidomide was able to induce HbF expression in CD34+ cells from patients with SCD, the authors suggested that it might provide a new therapy for SCD, either alone or in combination with hydroxurea.

Furthermore, because the induction of HbF has been shown to be of some benefit to individuals with beta-thalassemia (a hereditary anemia caused by decreased beta-globin production), the authors also suggested that pomalidomide might be a good therapeutic for the treatment of beta-hemoglobinopathies other than SCD, such as beta-thalassemia.

Source: Journal of Clinical Investigation

Explore further: Premature aging: Scientists identify and correct defects in diseased cells

Related Stories

Electricity generating nano-wizards

19 minutes ago

Just as alchemists always dreamed of turning common metal into gold, their 19th century physicist counterparts dreamed of efficiently turning heat into electricity, a field called thermoelectrics. Such scientists had long ...

Topology looks for the patterns inside big data

39 minutes ago

Big data gets much attention from media, industry and government. Companies and labs generate massive amounts of data associated with everything from weather to cell phone usage to medical records, and each data set may involve hundreds of variables. ...

New way to cool micro-electronic devices

39 minutes ago

(Phys.org)—A team of researchers working at the University of Grenoble has developed a new way to cool solids at the micro level. In their paper published in Physical Review Letters, the team describes how th ...

Brain learning simulated via electronic replica memory

39 minutes ago

Scientists are attempting to mimic the memory and learning functions of neurons found in the human brain. To do so, they investigated the electronic equivalent of the synapse, the bridge, making it possible for neurons to ...

Recommended for you

Why you need one vaccine for measles and many for the flu

23 hours ago

While the influenza virus mutates constantly and requires a yearly shot that offers a certain percentage of protection, old reliable measles needs only a two-dose vaccine during childhood for lifelong immunity. ...

Scientists turn blood into neural cells

23 hours ago

Scientists at McMaster University have discovered how to make adult sensory neurons from human patients simply by having them roll up their sleeve and providing a blood sample.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.